Executive Director
Peter Lamy Center on Drug Therapy and Aging
Dr. Brandt is a professor of pharmacy practice and science and executive director of the Peter Lamy Center on Drug Therapy and Aging. Since joining the University of Maryland, School of Pharmacy, she has expanded geriatric training opportunities available, including the geriatrics/palliative care pathway, ASHP-accredited geriatrics residency, and 2-year post PharmD Fellowship. As a practicing pharmacist in geriatrics for nearly 20 years and a nationally known leader in geriatric pharmacy, Dr. Brandt leverages her professional collaborations as well as experiences to improve medication safety in older adults. The collaborations created are a result of years working in the field of geriatric pharmacotherapy as a practitioner, educator, researcher, advocate as well as now the Executive Director of the Lamy Center. The Lamy’s Center mission is dedicated to improving drug therapy for aging adults through innovative research, education, and clinical initiatives. The Lamy Center has a legacy of partnering with others throughout Maryland at senior centers, senior housing communities, numerous healthcare systems and our own PATIENTs program. Recent research funding has afforded the opportunity to lead the work with beneficiaries, caregivers and case managers nationally to gauge aspects of the Medicare Part D Medication Therapy Management service that are of value to help propose future program modifications to the Centers of Medicare and Medicaid Services. This work highlights the importance of patient centered care approaches and supportive workflow integration.
She has worked on various interdisciplinary teams across numerous practice settings, and is currently leading initiatives to integrate sustainable pharmacist-directed services to help older adults with multiple co-morbidities at the MedStar Center for Successful Aging. Dr. Brandt has been active in promoting optimal care for older adults and has affected this through her educational, clinical, as well as health care policy work. She has directed projects with multiple stakeholders focusing on Medicare Part D Medication Therapy Management programs, high risk medications, and medication stewardship. Her public policy advocacy occurs on both a state and national level. She is one of the authors of the 2012, 2015 and 2019 American Geriatrics Society Beer’s Criteria and the past President and Board Chairman of American Society of Consultant Pharmacists.